Press Releases

Alere is leading the industry in informed, connected healthcare. Explore our news room to see how.

  • All
  • Corporate / Financial
  • Cardiometabolic
  • Connected Health
  • Health Information Solutions
  • Infectious Disease
  • Toxicology
  • Women's health
Date Press Release PDF
Dec 12
Dr. Regina Benjamin Joins Alere Board
Oct 29
Alere Inc. Announces Q3 2013 Results
Oct 29
First rapid diagnostic test to detect both HIV-1 antigen and HIV-1/2 antibodies now available.
Oct 23
Alere’s “Test Target Treat™” Campaign to Partner with the Alliance for the Prudent Use of Antibiotics on an Educational Program to Control Antimicrobial Resistance
Oct 22
Alere Inc. Schedules Conference Call for 8:30 a.m. ET October 29, 2013 to Discuss Third Quarter 2013 Results
Sep 23
Alere Partners with Malaria No More on Power of One Campaign in the Fight Against Malaria
Sep 11
UK collaborates with Alere to transform health service outcomes
Aug 09
Alere receives FDA Approval for Alere Determine™ HIV-1/2 Ag/Ab Combo
Aug 08
Alere Analytics Launches Electronic Laboratory Reporting (ELR) Solution to Help Hospitals Automate Public Health Submissions and Satisfy Meaningful Use Requirements
Aug 05
Alere™ MobileLink Receives FDA Clearance
Jul 31
Alere Inc. Announces Q2 2013 Results
Jul 18
Alere Inc. Schedules Conference Call for 8:30 a.m. ET July 31, 2013 to Discuss Second Quarter 2013 Results
Jun 27
Alere Supports National HIV Testing Day
Jun 06
Australian Men Continue to Bridge Gender Health Gap
Jun 04
Alere Analytics Launches Hospital Clinical Surveillance Solution for Infection Control and Medication Management at the 40th Annual APIC Conference
May 30
Australian Smokers Perform Worse on All Lifestyle Indices than Non-smokers
May 09
Alere Inc. Announces Q1 2013 Results
May 02
Alere Inc. Schedules Conference Call for 8:30 a.m. ET May 9, 2013 to Discuss First Quarter 2013 Results
May 01
American Diabetes Association® and Alere™ Wellbeing to Offer Weight Loss Programs to Employers
Mar 13
Alere to Launch “Test Target Treat™" Campaign at 9th Annual International Symposium on Antimicrobial Agents and Resistance
Mar 11
Screening for BNP and Targeted Care Reduce Heart Failure in At-Risk Patients
Mar 01
Alere to Develop Simple, Affordable Point-of-Care Nucleic Acid Test for Tuberculosis & Expand Manufacturing for POC HIV Viral Load Platform
Feb 15
Alere Inc. Announces Q4 2012 Results
Feb 08
Alere Inc. Schedules Conference Call for 8:30 a.m. ET February 15, 2013 to Discuss Fourth Quarter 2012 Results
Feb 04
Alere Acquires Epocal, Inc.

Be Alerted

Stay alerted about our latest news and announcements

Sign Up

©2010-2015 Alere. All rights reserved. The Alere Logo and Alere are trademarks of the Alere group of companies. All other trademarks referenced are trademarks of their respective owners. This website is governed by applicable U.S. laws and governmental regulations. The products and information contained herewith may not be accessible in all countries, and Alere takes no responsibility for such information which may not comply with local country legal process, regulation, registration and usage. Your use of this website and the information contained herein is subject to our Website Terms and Conditions and Privacy Policy. Photos displayed are for illustrative purposes only. Any person depicted in such photographs is a model.